Metrics

Valuation  
Market cap $ 1.381B
Market cap (USD) —
P/E 7.76
PEG —
P/BV 3.29
P/S —
P/OCF 81.81
P/FCF 129.79
Dividend yield —
Turnover / mcap —
Returns  
ROE -1.3%
ROI -1.2%
ROIC -3.3%
Profit margin -4.8%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 33
Quality score -41.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 96.214M 82.254M 143.271M 161.759M 119.156M 48.087M 27.371M 19.742M 11.022M 8.227M 6.449M 6.191M 8.949M 5.663M 2.759M 2.082M
Net profit -4.595M -20.184M -66.427M -139.805M -7.635M 2.667M -1.657M 3.266M -2.515M -6.875M -4.214M -3.218M -1.084M -1.66M -1.957M -1.984M
Free cash flow 10.637M 5.204M -18.879M -18.873M -12.978M 4.684M 538K 1.848M 461.355K -4.471M -5.108M -3.752M -90.663K -296.786K -1.083M -1.281M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 24.18 25.96 16.25 18.2 37.27 39.89 16.18 12.03 6 1.61 2.19 1.64 — — — —
Price performance 12m -0.07 0.6 -0.11 -0.51 -0.07 1.47 0.35 1 2.73 -0.26 0.33 — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

On January 8, 2026, Karen Foster, the Chief Quality and Operations Officer of BioLife Solutions, Inc. (the “Company”), provided notice of her decision to retire from her position as Chief Quality and Operations Officer of the Company, effective March 31, 2026. Ms. Foster’s decision to retire from her position with the Company was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company appreciates Ms. Foster’s services to the Company and wishes her the best in retirement.

Prompts

Biolife Solutions Inc (ticker BLFS), listed in United States.

Company History

Date Change Detail
Aug 6, 2026 Acquired by Acquired by Repligen Corporation (CIK 730272).
Jan 21, 2004 Renamed CRYOMEDICAL SCIENCES INC → BIOLIFE SOLUTIONS INC

ETFs Holding Biolife Solutions Inc

ETF Weight in ETF Shares Market value As of
EVNT 2.39% 8,433 $ 312.611K Aug 31, 2026
RUSC 0.16% 4,484 $ 126.628K Jun 30, 2026
MSSM 0.02% 3,602 $ 133.526K Aug 31, 2026